DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170097

The importance of HbA1C and erythrocyte sedimentation rate as prognostic factors in predicting the outcome of diabetic foot ulcer disease

Pal Bikramjit, Nagaraju Raveender, Pal Sudipta

Abstract


Background: The study is to determine the relation between the high HbA1c and ESR as prognostic factors with the severity of the diabetic foot ulcer disease, particularly, in predicting the final outcome in the form of higher incidence of lower extremity amputation (LEA) and/or prolonged hospital stay. The study explored the importance of increased level of serum HbA1c and erythrocyte sedimentation rate (ESR) in determining the final outcome of the disease. It revealed that the severity of diabetic foot ulcer disease is more in patients who had concomitant high levels of baseline HbA1c and ESR on admission.

Methods: This observational study was done in 89 patients who were admitted in the surgical wards of the two teaching hospitals in India. The cohort consisted of patients from the age of 26 to 83 years of age who presented with clinically infected foot ulcers. Routine blood tests were done which include HbA1C on the day of admission and fasting ESR (1st hour) on the next day morning. The standard X-ray plates were routinely taken on the first day for determination of the involvement of underlying bones and soft tissues. The outcome of the diabetic foot ulcer was assessed from the severity of the disease according to Meggit-Wagner classification, the incidence of lower extremity amputation and the duration of hospital stay.

Results: The high levels of baseline HbA1C (more than 7.0%) in blood on the first day of admission was found in all of the 89 patients who were included in this study but the criteria for consideration of high risk was more than 9% which was found in 41 patients. The criteria for consideration of high ESR in this study was set to be 50 mm/h. High ESR of more than 50 mm was found in 63 patients. We had subdivided 31 patients into a High Risk Group whose baseline levels of HbA1C > 9% and ESR > 50 mm/h. The incidence of amputation was 79.31% and 44.44% with HbA1c of more than 9.0% and ESR of more than 50 mm respectively and was considerably increased (83.87%) when both HbA1c and ESR were more than the critical value as set in the study. Similarly, the incidence of prolonged hospital stay of more than 14 days was 58.54% in patients with HbA1C level of greater than 9 %, 51.85% in patients with baseline ESR > 50 mm/h and 93.55% in presence of high levels of both HbA1C (>9%) and ESR (>50 mm/h)..

Conclusions: The study observed that the patients who presented with baseline high levels of HbA1C, ESR or both on admission had unfavourable prognosis with increased incidence of lower extremity amputation and prolonged hospital stay than the other patients in the cohort. 


Keywords


Amputation and DFU, ESR and LEA, ESR and Hospital stay, Hospital stay and DFU, HbA1C and Hospital stay, LEA and HbA1C

Full Text:

PDF

References


Indian Heart Association. Why south asians facts. Available at http://indianheartassociation.org/why-indians-why-south-asians/overview. Accessed on 12 June 2016.

Diabetes can be controlled in 80 percent of Cases in India. Available at http:// www.bihartimes.in/ Newsbihar/ 2014/ Feb/ newsbihar 06 Feb8. html. Accessed on 12 June 2016.

Ramachandran A, Ma RCW, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:408-18.

Shankhdhar KLK, Shankhdhar U, Shankhdhar S. Diabetic foot problems in India an overview and potential simple approaches in a developing country. Current Diabetes Reports. 2008;8:452-7.

Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Harris MI, Cowie C, Stern MP, (Eds). Diabetes in America. (2ndedn), USA: NIH Publication. 1995;409-27.

Levin ME. In: Preventing amputation in the patient with diabetes. Diabetes Care. 1995;18:1383-94.

Shobhana R, Rao PR, Lavanya A, Vijay V, Ramachandran A. Cost burden to diabetic patients with foot complications: a study from Southern India. J Assoc Physicians India. 2000;48:1147-50.

Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower extremity ulcers. Diabetes Care. 2000;23:1333-8.

Palumbo PJ, Melton LJ. Peripheral vascular disease and diabetes. In: Harris MI, Hamman RF. Diabetes in America. Washington: US Government Printing Office; 1985:16-21.

Pendsey S. Diabetic foot: a clinical atlas. Jaypee Brothers Medical Publishers. 2003.

Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: Basis for prevention. Diabetes Care. 1990;13:513-21.

Zhao W, Katzmarzyk PT, Horswell R. HbA1c and lower-extremity amputation risk in low-income patients with diabetes. Diabetes Care. 2013;36:3591-8.

Adler A, Erqou S, Lima TAS. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus review and meta-analysis. Diabetologia. 2010;53:840-9.

Butalia S, Palda VA, Sargeant RJ, Detsky AS, Mourad O. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA. 2008;299:806-13.

Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2:64-122.

Hemoglobin A1c test. Medicine Net. com. http:// www.medicinenet.com/hemoglobin_a1c_test/articl.htm. Retrieved 2007-12-26. Accessed on 18 March 2016.

Hasan CMMR, Parial MM, Kasru A. Association of HbA1c, creatinine and lipid profile in patients with diabetic foot ulcer. Middle-East J Scientific Res. 2013;16(11):1508-11.

Adler AI, Erqou S, Lima TAS, Robinson TAH. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus review and meta-analysis. Diabetologia. 2010;53:840-9.

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Statist Assn. 1958;53(282):457-81.

Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J. HbA1c and lower-extremity amputation risk in low-income patients with diabetes. Diabetes Care. 2013;36(11):3591-8.

Lacle A, Luis F, Juan V. Diabetes-related lower-extremity amputation incidence and risk factors: a prospective seven-year study in costa rica. Rev Panam Salud Publica. 2012;32(3):55-7.

Kogani M, Mansournia MA, Irani AD, Naieni KH. Risk factors for amputation in patients with diabetic foot ulcer in southwest Iran: a matched case-control study. Epidemiol Health. 2015;37:e2015044.

Li X, Xiao T, Wang Y, Gu H, Liu Z, Jiang Y. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Res Clin Pract. 2011;93:26-30.

Mashaekhi M, Larijani B, Mohajerani MR, Rambod K. Prevalence of amputation in patients with diabetic foot ulcer has been hospitalized at the Shariati Hospital; 2002-2011. Iran J Diabet Lipid Disord. 2013;12:543-54.

Akinci B, Yener S, Yesil S, Yapar N, Kucukyavas Y, Bayraktar F. Acute phase reactants predict the risk of amputation in diabetic foot infection. J Am Podiatr Med Assoc. 2011;101:1-6.

Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35:280-3.

Fleischer AE, Didyk AA, Woods JB, Burns SE, Wrobel JS, Armstrong DG. Combined clinical and laboratory testing improves diagnostic accuracy for osteomyelitis in the diabetic foot. J Foot Ankle Surg. 2009;48(1):39-46.

Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288-93.

Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc. 2001;91(9):445-50.

Newman LG, Waller J, Palestro CJ. Unsuspected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. J Am Med Asso. 1991;266:1246-51.

Eneroth M, Larsson J, Apelqvist J. Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications. 1999;13:254-63.

Yesil S, Akinci B, Yener S, Bayraktar F, Karabay O, Havitcioglu H. Predictors of amputation in diabetics with foot ulcer: single center experience in a large Turkish cohort. Hormones (Athens). 2009;8(4):286-95.

Marston WA. Dermagraft Diabetic Foot ulcer Study Group. Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycemia. Ostomy Wound Manage. 2006;52:26-32.

Mohieldein AH, Abdelkarim AM, Osman FM, Abdallah EM, Ali MM. HbA1c as a marker to reduce lower limb amputation in patients with type 2 diabetes mellitus. Sudan J Med Sci. 2008;3(3):227-32.

Zhou ZY, Liu YK, Chen HL, Yang HL, Liu F. HbA1c and lower extremity amputation risk in patients with diabetes a meta-analysis. Int J Lower Extremity Wounds. 2015;14(2):168-77.